Follow
Inaki Etxeberria
Inaki Etxeberria
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Cytokines in clinical cancer immunotherapy
P Berraondo, MF Sanmamed, MC Ochoa, I Etxeberria, MA Aznar, ...
British journal of cancer 120 (1), 6-15, 2019
9362019
CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity
Á Teijeira, S Garasa, M Gato, C Alfaro, I Migueliz, A Cirella, C de Andrea, ...
Immunity 52 (5), 856-871. e8, 2020
4632020
An RNA toolbox for cancer immunotherapy
F Pastor, P Berraondo, I Etxeberria, J Frederick, U Sahin, E Gilboa, ...
Nature Reviews Drug Discovery 17 (10), 751-767, 2018
1962018
Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy
AR Sanchez‐Paulete, S Labiano, ME Rodriguez‐Ruiz, A Azpilikueta, ...
European journal of immunology 46 (3), 513-522, 2016
1412016
Intratumor adoptive transfer of IL-12 mRNA transiently engineered antitumor CD8+ T cells
I Etxeberria, E Bolaños, JI Quetglas, A Gros, A Villanueva, J Palomero, ...
Cancer Cell 36 (6), 613-629. e7, 2019
1092019
Immunotherapeutic effects of intratumoral nanoplexed poly I: C
MA Aznar, L Planelles, M Perez-Olivares, C Molina, S Garasa, I Etxeberría, ...
Journal for immunotherapy of cancer 7, 1-16, 2019
1082019
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
I Etxeberria, J Glez-Vaz, Á Teijeira, I Melero
ESMO open 4, e000733, 2019
1072019
Revisiting interleukin-12 as a cancer immunotherapy agent
P Berraondo, I Etxeberria, M Ponz-Sarvise, I Melero
Clinical Cancer Research 24 (12), 2716-2718, 2018
922018
TGFβ blockade enhances radiotherapy abscopal efficacy effects in combination with anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies
ME Rodríguez-Ruiz, I Rodríguez, L Mayorga, T Labiano, B Barbes, ...
Molecular cancer therapeutics 18 (3), 621-631, 2019
742019
Cellular cytotoxicity is a form of immunogenic cell death
L Minute, A Teijeira, AR Sanchez-Paulete, MC Ochoa, M Alvarez, I Otano, ...
Journal for immunotherapy of cancer 8 (1), 2020
702020
Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) costimulation
A Teijeira, S Labiano, S Garasa, I Etxeberria, E Santamaría, A Rouzaut, ...
Cancer immunology research 6 (7), 798-811, 2018
702018
Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant semliki forest virus–derived vectors fosters dendritic cell–mediated T-cell cross-priming
AR Sánchez-Paulete, Á Teijeira, JI Quetglas, ME Rodríguez-Ruiz, ...
Cancer Research 78 (23), 6643-6654, 2018
672018
Intercellular adhesion molecule-1 and vascular cell adhesion molecule are induced by ionizing radiation on lymphatic endothelium
ME Rodriguez-Ruiz, S Garasa, I Rodriguez, JL Solorzano, B Barbes, ...
International Journal of Radiation Oncology* Biology* Physics 97 (2), 389-400, 2017
622017
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
SS Chandran, J Ma, MG Klatt, F Dündar, C Bandlamudi, P Razavi, ...
Nature medicine 28 (5), 946-957, 2022
582022
Metabolic consequences of T-cell costimulation in anticancer immunity
A Teijeira, S Garasa, I Etxeberria, M Gato-Cañas, I Melero, GM Delgoffe
Cancer immunology research 7 (10), 1564-1569, 2019
522019
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell–Relevant Genes
MA Aznar, S Labiano, A Diaz-Lagares, C Molina, S Garasa, A Azpilikueta, ...
Cancer immunology research 6 (1), 69-78, 2018
422018
CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes
S Labiano, F Meléndez-Rodríguez, A Palazón, Á Teijeira, S Garasa, ...
Oncoimmunology 6 (4), e1283468, 2017
382017
Twists and turns to translating 4-1BB cancer immunotherapy
MF Sanmamed, I Etxeberría, I Otano, I Melero
Science translational medicine 11 (496), eaax4738, 2019
372019
Anti-CD137 and PD-1/PD-L1 antibodies en route toward clinical synergy
E Pérez-Ruiz, I Etxeberria, ME Rodriguez-Ruiz, I Melero
Clinical Cancer Research 23 (18), 5326-5328, 2017
372017
Repurposing the yellow fever vaccine for intratumoral immunotherapy
MA Aznar, C Molina, A Teijeira, I Rodriguez, A Azpilikueta, S Garasa, ...
EMBO Molecular medicine 12 (1), e10375, 2020
312020
The system can't perform the operation now. Try again later.
Articles 1–20